Eastwood Bio-Medical Canada Inc
XTSX:EBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Eastwood Bio-Medical Canada Inc
Cash from Operating Activities
Eastwood Bio-Medical Canada Inc
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Eastwood Bio-Medical Canada Inc
XTSX:EBM
|
Cash from Operating Activities
-CA$73k
|
CAGR 3-Years
-168%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash from Operating Activities
$1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
5%
|
CAGR 10-Years
-5%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Cash from Operating Activities
-CA$78.7m
|
CAGR 3-Years
48%
|
CAGR 5-Years
33%
|
CAGR 10-Years
-18%
|
|
|
Cronos Group Inc
TSX:CRON
|
Cash from Operating Activities
$25.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Cash from Operating Activities
-$113.9m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-117%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cash from Operating Activities
CA$69m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
25%
|
|
Eastwood Bio-Medical Canada Inc
Glance View
Eastwood Bio-Medical Canada, Inc. is a natural health supplement distribution company. The company is headquartered in Richmond, British Columbia. The company went IPO on 2014-09-05. The firm is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients. The Eleotin products include natural remedies for certain metabolic disorders such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. The firm's licensed products include Eleotin A 700, which is a treatment for spleen deficiency, lack of appetite and fatigue; Eleotin AL88, a laxative; Eleotin Cal20, for bone and teeth maintenance; Eleotin V3D for the development and maintenance of bones and teeth; Eleotin G2000 for cardiovascular health; Eleotin H55, a sedative and tension relief, Eleotin Zn330, which is involved in tissue formation and metabolism; Eleotin Bentley, which is used to promote healthy glucose levels, and Eleotin LBM, which is recommended for hypertension relief.
See Also
What is Eastwood Bio-Medical Canada Inc's Cash from Operating Activities?
Cash from Operating Activities
-73k
CAD
Based on the financial report for Jan 31, 2026, Eastwood Bio-Medical Canada Inc's Cash from Operating Activities amounts to -73k CAD.
What is Eastwood Bio-Medical Canada Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
29%
Over the last year, the Cash from Operating Activities growth was -312%. The average annual Cash from Operating Activities growth rates for Eastwood Bio-Medical Canada Inc have been -168% over the past three years , 29% over the past five years .
